期刊文献+

低分子肝素对血液透析患者血小板活化状态的影响 被引量:2

Effect of low molecular weight hepain on mean platelet volume and alpha-granule membrane protein in patients treated with hemodlalysis
下载PDF
导出
摘要 目的:研究低分子量肝素(LMWH)对血液透析(血透)患者血小板平均体积(MPV)和a颗膜粒膜蛋白(GMP-140)的影响。方法对45例维持性血透患者分别使用LMWH和标准肝素(SH)抗凝,分别测定透析前、透析后15、30、60、120、240分钟时活化的部分凝血酶时间(APTT)和凝血酶时间(TT)及血小板计数(BPC)、MPV、GMP-140并作比较。结果SH组APTT和TT在透析120及240分钟时较之LMWH组显著延长(P均<0.001),透析15分钟后SH组MPV、GMP-140较透析前及LMWH组有极显著增高(P均<0.01)。结论SH是引起血透过程中血小板活化的重要因素之一,LMWH能显著改善这种状况。 Objectives To investigate the effect of low molecular weight heparin on meanplatelet volume (MPV) and alpha-granule membrane protein (GMP-140) in patients with hemodialysis (HD). Methods 45 patients with HD were treated with same HD fashion and used either withlow molecular weighyt heparin (LMWH)or standard heparin (SH). The active partial thromboplasintime (APTT), thrombin time (TT) , BPC, MPV , GMP-140 were measured at prior-HD and 15,3O, 60, 120, 240 minutes after HD,respectively. Results APTT and TT were markedly prolongatedat 120, 240 minutes after HD in SH group than those in LMWH group (all P<0. 001). MPV andGMP-140 were much significantly higher at 15 minutes after HD in SH than those in LMWH group(all PRO. 01). Conclusion The SH might be an important factor contributing to platelet activation and that LMWH can improve platelet activation during HD.
出处 《临床内科杂志》 CAS 1999年第2期92-94,共3页 Journal of Clinical Internal Medicine
关键词 肝素 血液透析 血小板平均体积 : Heparin Bemodialysis Mean platelet volume Platelet alpelet alphagranule mimbrane protein.
  • 相关文献

参考文献3

共引文献95

同被引文献21

  • 1陈德,华尔铨,张书富,郑鹏翔.低分子肝素联合阿司匹林对急性冠状动脉综合征患者血小板功能的影响[J].中国综合临床,2005,21(4):289-290. 被引量:9
  • 2汤立,侯健全.P-选择素与血液透析[J].国际移植与血液净化杂志,2006,4(4):10-13. 被引量:2
  • 3胡海澜,杨进顺,黄文铎,吴波以,冯莹.建立下肢骨折术后并发深静脉栓塞预警机制的可行性研究[J].血栓与止血学,2006,12(4):149-151. 被引量:19
  • 4邱贵兴,杨庆铭,余楠生,翁习生,王凯,李晓林.低分子肝素预防髋、膝关节手术后下肢深静脉血栓形成的多中心研究[J].中华骨科杂志,2006,26(12):819-822. 被引量:428
  • 5Gritters M, Borgdorff G, Grooteman MP, et al. Platelet activation in clinical haemodialysis:LMWH as a major contributor to bio - incompatibility ? Nephrol Dial Transplant, 2008,23 ( 9 ) : 2911 - 2917.
  • 6Aggarwal A, Whitaker DA, Rinmer JM, et al. Attenuation of platelet reactivity by enoxaparin compared with unfractionated heparin in patients undergoing hemodialysis. Nephrol Dial Trans- plant,2004,19 (6) : 1559 - 1563.
  • 7Kobusiak- Prokopowicz M, Kuliczkowski W, Karolko B, et al. Platelet aggregation and P - selectin levels during exercise tread- mill test in patients with ischaemic heart disease. Kardiol Pol, 2006,64(10) :1094 - 1100.
  • 8Kyrle PA, Hron G, Eichinger S, et al. Circulating P- selectin and the risk of recurrent venous thromboem- bolism. Thromb Haemost, 2007, 97 (6): 880-883.
  • 9Ay C, Jungbauer LV, Kaider A, et al. P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism. Thromb Haemost, 2008, 99 (5): 899-904.
  • 10Ay C, Jungbauer LV, Sailer T, tions of soluble P-selectin are venous thromboembolism and variant. Clin Chem, 2007, 53 et al. High eoneentra- associated with risk of the P-selectin Thr715 (7): 1235-1243.

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部